Together, these findings not only demonstrate that SOID-8 blocks the JAK2/STAT3 signaling in vitro and in vivo, but also provide a potential novel lead compound for further development of new preventive and therapeutic agents for melanoma. The gene discussed is JAK2; the disease is melanoma.